1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
CVOT Summit Report 2023 : new cardiovascular, kidney, and metabolic outcomes
(
- Contribution to journal › Debate/Note/Editorial
- 2023
-
Mark
Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR : Interpretation According to Performance Compared to Measured GFR
(
- Contribution to journal › Article
-
Mark
CKD-EPI and EKFC GFR Estimating Equations: Performance and Other Considerations for Selecting Equations for Implementation in Adults
(
- Contribution to journal › Article
-
Mark
Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes : A genetic association study in Europeans
(
- Contribution to journal › Article
-
Mark
Identification of biomarkers for glycaemic deterioration in type 2 diabetes
(
- Contribution to journal › Article
- 2021
-
Mark
New creatinine- and cystatin C-based equations to estimate GFR without race
(
- Contribution to journal › Article
-
Mark
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables : an IMI-RHAPSODY study
(
- Contribution to journal › Article
-
Mark
Distinct Molecular Signatures of Clinical Clusters in People with Type 2 Diabetes : an IMIRHAPSODY Study
(
- Contribution to journal › Article
- 2020
-
Mark
Performance of Indexed and Nonindexed Estimated GFR
(
- Contribution to journal › Letter
-
Mark
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes
(
- Contribution to journal › Article